| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | -10.3% |
| SG&A Expense | $11.0M | -78.5% |
| Operating Income | -$12.1M | +77.0% |
| Interest Expense | $575K | +0.0% |
| Income Tax | $0 | — |
| Net Income | -$12.1M | -218.6% |
| EPS (Basic) | -$0.02 | -200.0% |
| EPS (Diluted) | -$0.02 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -27.3% |
| Current Assets | $4.8M | -27.2% |
| Total Assets | $4.9M | -27.2% |
| Current Liabilities | $49 | -97.2% |
| Stockholders' Equity | $1.4M | -56.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +13.1% |
| Financing Cash Flow | $1K | -100.0% |